Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Operating Expenses (2020 - 2025)

Historic Operating Expenses for IDEAYA Biosciences (IDYA) over the last 6 years, with Q4 2025 value amounting to $105.4 million.

  • IDEAYA Biosciences' Operating Expenses fell 3023.2% to $105.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $204.8 million, marking a year-over-year decrease of 3866.97%. This contributed to the annual value of $378.0 million for FY2025, which is 1318.9% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Operating Expenses stood at $105.4 million for Q4 2025, which was down 3023.2% from $99.4 million recorded in Q3 2025.
  • Over the past 5 years, IDEAYA Biosciences' Operating Expenses peaked at $151.1 million during Q4 2024, and registered a low of $16.4 million during Q1 2021.
  • In the last 5 years, IDEAYA Biosciences' Operating Expenses had a median value of $35.2 million in 2023 and averaged $49.3 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Operating Expenses soared by 22971.49% in 2024 and then plummeted by 3023.2% in 2025.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Operating Expenses stood at $21.3 million in 2021, then surged by 42.82% to $30.5 million in 2022, then skyrocketed by 50.46% to $45.8 million in 2023, then surged by 229.71% to $151.1 million in 2024, then plummeted by 30.23% to $105.4 million in 2025.
  • Its Operating Expenses stands at $105.4 million for Q4 2025, versus $99.4 million for Q3 2025 and $151.1 million for Q4 2024.